Invivyd (IVVD) Net Cash Flow (2021 - 2025)

Invivyd (IVVD) posted Net Cash Flow of $141.7 million for Q4 2025, up 183.09% on a QoQ basis from $50.1 million in Q3 2025, and up 477.64% year-over-year from $24.5 million in Q4 2024.

Invivyd (IVVD) Net Cash Flow (2021 - 2025) Analysis & Trends

Invivyd's Net Cash Flow history runs 5 years deep, the most recent figure standing at $141.7 million for Q4 2025.

  • Quarterly Net Cash Flow rose 477.64% year-over-year to $141.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $157.3 million (up 219.83% YoY) and the FY2025 annual result came in at $157.3 million, up 219.83% from the prior year.
  • Net Cash Flow was $141.7 million for Q4 2025 at Invivyd, up from $50.1 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $301.3 million in Q2 2021 and bottomed at -$196.7 million in Q3 2022.
  • A 5-year average of $5.6 million and a median of -$10.6 million in 2022 frame the typical range for Net Cash Flow.
  • Annual changes were most pronounced in 2024 — Net Cash Flow sank 817.08% — and 2025, when it surged 477.64%.
  • Invivyd's Net Cash Flow stood at $64.0 million in 2021, then sank by 390.95% to -$186.1 million in 2022, then surged by 110.11% to $18.8 million in 2023, then tumbled by 299.42% to -$37.5 million in 2024, then jumped by 477.64% to $141.7 million in 2025.
  • Business Quant data shows IVVD's Net Cash Flow at $141.7 million in Q4 2025, $50.1 million in Q3 2025, and -$13.2 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 10.56 Mn
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -2.44 Mn
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 224.46 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 457.40 Mn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -152.20 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 57.19 Mn
10 Invivyd 104.07 Mn -122.62 Mn 16.07 Mn 141.72 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 141.72 Mn
Dec 31, 2025 141.72 Mn
Sep 30, 2025 50.06 Mn
Sep 30, 2025 50.06 Mn
Jun 30, 2025 -13.18 Mn
Jun 30, 2025 -13.18 Mn
Mar 31, 2025 -21.26 Mn
Mar 31, 2025 -21.26 Mn
Dec 31, 2024 -37.53 Mn
Dec 31, 2024 -37.53 Mn
Sep 30, 2024 -41.01 Mn
Sep 30, 2024 -41.01 Mn
Jun 30, 2024 -41.51 Mn
Jun 30, 2024 -41.51 Mn
Mar 31, 2024 -11.25 Mn
Mar 31, 2024 -11.25 Mn
Dec 31, 2023 18.82 Mn
Dec 31, 2023 18.82 Mn
Sep 30, 2023 59.88 Mn
Sep 30, 2023 59.88 Mn